Filing Details

Accession Number:
0001209191-14-067416
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-07 20:00:22
Reporting Period:
2014-11-05
Filing Date:
2014-11-07
Accepted Time:
2014-11-07 20:00:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001233 Sangamo Biosciences Inc SGMO Biological Products, (No Disgnostic Substances) (2836) 680359556
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202278 G Dale Ando C/O Sangamo Biosciences Inc.,
Point Richmond Tech Cntr, 501 Canal Blvd
Richmond CA 94804
Vp, Therapeutic Dev. & Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-05 6,798 $4.11 104,654 No 4 M Direct
Common Stock Acquisiton 2014-11-05 8,202 $6.82 112,856 No 4 M Direct
Common Stock Disposition 2014-11-05 15,000 $11.35 97,856 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-11-05 6,798 $0.00 6,798 $4.11
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-11-05 8,202 $0.00 8,202 $6.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-12-11 No 4 M Direct
41,798 2016-12-12 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on June 23, 2014.
  2. Includes 33,333 shares, 23,333 shares, and 23,000 shares subject to restricted stock units granted on December 8, 2011, December 6, 2012, and December 12, 2013, respectively, that will be issued as such units vest in accordance with their terms.
  3. Includes 1,277 shares acquired by the Reporting Person on October 31, 2014 under the Issuer's Employee Stock Purchase Plan.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.15 to $11.64, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  5. All shares underlying this option are vested and immediately exercisable.